glp-1 and oral contraceptives Can Tirzepatide Make Birth Control Pills Less Effective? Dr. Peter A. Khamvongsa |

Higher Dosage Approval: The FDA approved a new, higher 7.2 mg dose of Wegovy (Wegovy HD), designed to achieve greater, long-term weight reduction.Safety Concerns & Regulations: Reports have linked Wegovy to a potential risk of "eye stroke" (ischemic optic neuropathy)

Because GLP-1 receptor agonist medications slow gastric emptying, some patients may retain significant amounts of food or fluid in the stomach even after standard preoperative fasting periods

Eligibility involves more than simply having Medicare

These changes are crucial for individuals with obesity and Type 2 diabetes, as they address both weight and metabolic health

"The results were remarkable